BLK:NYSEBlackRock, Inc. Analysis
Data as of 2026-03-09 - not real-time
$957.67
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
BlackRock’s stock is currently trading below its short‑term moving averages and the RSI signals oversold conditions, while the MACD histogram remains negative, indicating bearish momentum. The beta above one and elevated 30‑day volatility point to heightened price swings, yet the DCF fair‑value estimate suggests a substantial upside potential. The trailing P/E sits well above the asset‑management industry average, but the forward P/E compresses, and a dividend yield near 2% adds income appeal.
Recent material news highlights a dividend increase and a first‑quarter dividend payout, but also underscores stress in the private‑credit space with large redemption requests and a loan write‑off that pressured the share price. Analyst consensus remains bullish with a “buy” rating and an upgraded price target, reflecting confidence in revenue growth, strong cash generation, and the firm’s market position. Balancing the technical weakness with solid fundamentals and upside from valuation models leads to a nuanced view: short‑term caution, medium‑term buying opportunity, and long‑term confidence.
Recent material news highlights a dividend increase and a first‑quarter dividend payout, but also underscores stress in the private‑credit space with large redemption requests and a loan write‑off that pressured the share price. Analyst consensus remains bullish with a “buy” rating and an upgraded price target, reflecting confidence in revenue growth, strong cash generation, and the firm’s market position. Balancing the technical weakness with solid fundamentals and upside from valuation models leads to a nuanced view: short‑term caution, medium‑term buying opportunity, and long‑term confidence.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Technical indicators show oversold momentum and bearish MACD
- Recent redemption pressure and loan write‑off increase near‑term uncertainty
- Elevated volatility and beta suggest heightened price swings
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF valuation indicates significant upside
- Strong revenue growth and cash flow generation
- Attractive dividend yield with sustainable payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Market‑leading scale and diversified global footprint
- Consistent earnings growth and robust balance sheet
- Long‑term dividend sustainability and defensive cash position
Key Metrics & Analysis
Financial Health
Revenue Growth23.40%
Profit Margin22.93%
P/E Ratio27.1
ROE10.72%
ROA3.47%
Debt/Equity24.37
P/B Ratio2.7
Op. Cash Flow$3.9B
Free Cash Flow$7.0B
Industry P/E17.4
Technical Analysis
TrendNeutral
RSI26.5
Support$919.03
Resistance$1,113.56
MA 20$1,061.76
MA 50$1,085.82
MA 200$1,085.51
MACDBearish
VolumeIncreasing
Fear & Greed Index100
Valuation
Fair Value$1,614.39
Target Price$1,320.94
Upside/Downside37.93%
GradeUndervalued
TypeBlend
Dividend Yield2.40%
Risk Assessment
Beta1.14
Volatility32.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.